Brampton, Canada Clinical Trials

A listing of Brampton, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 88 clinical trials
Study to Evaluate the Efficacy Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

This study will assess the efficacy of vibegron compared with placebo in men with overactive bladder (OAB) symptoms on pharmacological therapy for benign prostatic hyperplasia (BPH) as defined by micturition and urgency episodes.

cancer
nocturia
micturition chart
alpha blocker
vibegron
Private Practice
 (2.3 away) Contact site
  • 959 views
  • 15 Jul, 2021
  • +170 other locations
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

This study seeks to evaluate the safety and efficacy of brazikumab versus placebo (Stage I) and versus an active comparator (Stage 2) in participants with moderately to severely active CD and will include assessments of clinical response as demonstrated by improvement of symptoms and colonic mucosal appearance as observed on …

humira
endoscopy
prednisone
conventional treatment
methotrexate
Toronto Digestive Disease Associates Inc
 (10.0 away) Contact site
  • 400 views
  • 15 Sep, 2021
  • +320 other locations
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

A double-blind placebo controlled randomized Phase 3 study to determine if 80 or 100 mg of MGL-3196 as compared with placebo resolves NASH on liver biopsy and prevents progression to cirrhosis and/or advanced liver disease

mri-pdff
fibrosis
fibroscan
cirrhosis
hepatic fibrosis
Toronto Liver Center
 (19.6 away) Contact site
  • 167 views
  • 17 Jul, 2021
  • +229 other locations
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN (NCT03518086).

endoscopy
mirikizumab
Toronto Digestive Disease Associates, Inc.
 (10.0 away) Contact site
  • 386 views
  • 12 Sep, 2021
  • +912 other locations
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Participants will either get semaglutide tablets or placebo tablets ("dummy" medicine) - which treatment is decided by chance. Participants must take one tablet with water every morning on …

chronic disease
stroke
semaglutide
Novo Nordisk Investigational Site
 (2.4 away) Contact site
  • 1280 views
  • 12 Aug, 2021
  • +557 other locations
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults without a prior myocardial infarction (MI) or stroke who are at high risk of a cardiovascular event.

diabetes
arterial disease
stroke
infarct
myocardial infarction
Brampton Clinical Trials
 (1.7 away) Contact site
  • 542 views
  • 15 Sep, 2021
  • +1332 other locations
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (300/L). Eligible patients must have a history of 2 moderate and/or severe COPD exacerbations in the previous year …

severe chronic obstructive pulmonary disease
antibiotics
bronchodilator
eosinophil count
corticosteroids
Research Site
 (8.5 away) Contact site
  • 838 views
  • 10 Sep, 2021
  • +438 other locations
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.

abdominal pain
crohn's disease
remission
Toronto Digestive Disease Associates Inc
 (10.0 away) Contact site
  • 858 views
  • 23 Feb, 2021
  • +780 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
Toronto Digestive Diseases Ass /ID# 169106
 (10.0 away) Contact site
  • 618 views
  • 15 Sep, 2021
  • +926 other locations
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

This randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread to other parts of the body (metastatic). Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of tumor cells, either …

estrogen
paclitaxel
tumor cells
cancer
placebo administration
William Osler Health System-Brampton Civic Hospital
 (1.6 away) Contact site
  • 445 views
  • 15 Sep, 2021
  • +459 other locations